NA
RMD icon

NewEdge Advisors’s ResMed RMD Stock Holding History

NewEdge Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
1,813
-37
-2% -$7.67K ﹤0.01% 2365
2026
Q1 		$415K Sell
1,850
-95
-5% -$23.7K ﹤0.01% 2131
2025
Q4 		$468K Buy
1,945
+453
+30% +$116K ﹤0.01% 2013
2025
Q3 		$408K Sell
1,492
-113
-7% -$30.9K ﹤0.01% 1966
2025
Q2 		$414K Sell
1,605
-304
-16% -$72.5K ﹤0.01% 1811
2025
Q1 		$427K Sell
1,909
-219
-10% -$51.1K ﹤0.01% 1672
2024
Q4 		$487K Sell
2,128
-1,931
-48% -$465K ﹤0.01% 1578
2024
Q3 		$991K Buy
4,059
+2,365
+140% +$528K 0.01% 1118
2024
Q2 		$324K Buy
1,694
+1,549
+1,068% +$314K ﹤0.01% 1674
2024
Q1 		$28.7K Buy
145
+1
+0.7% +$183 ﹤0.01% 2495
2023
Q4 		$24.8K Sell
144
-100
-41% -$15.4K ﹤0.01% 2491
2023
Q3 		$36.1K Buy
244
+29
+13% +$5.24K ﹤0.01% 2194
2023
Q2 		$46.9K Buy
215
+83
+63% +$18.5K ﹤0.01% 2101
2023
Q1 		$29K Sell
132
-329
-71% -$71.4K ﹤0.01% 2214
2022
Q4 		$67.5K Buy
+461
New +$101K ﹤0.01% 1607
2022
Q1 		– Sell
-2,076
Closed -$541K – 1537
2021
Q4 		$541K Buy
+2,076
New +$539K 0.01% 1037
2021
Q1 		– Sell
-1,458
Closed -$310K – 1101
2020
Q4 		$310K Sell
1,458
-2,050
-58% -$409K 0.01% 752
2020
Q3 		$602K Buy
3,508
+614
+21% +$113K 0.02% 516
2020
Q2 		$556K Buy
2,894
+455
+19% +$74.4K 0.02% 505
2020
Q1 		$359K Sell
2,439
-1,436
-37% -$229K 0.02% 552
2019
Q4 		$600K Buy
3,875
+556
+17% +$80.1K 0.02% 473
2019
Q3 		$443K Buy
+3,319
New +$435K 0.02% 533

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NewEdge Advisors's RMD Position: Q2 2026 in Review

NewEdge Advisors reduced its ResMed (RMD) stake by 2% in Q2 2026, selling an estimated $7.67K and leaving 1,813 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #2365.

NewEdge Advisors first reported a position in RMD in Q3 2019 and has held it in 22 quarters since. The position peaked at $991K in Q3 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • NewEdge Advisors held 1,813 shares of ResMed worth $353K as of Q2 2026.
  • NewEdge Advisors sold 37 ResMed shares in Q2 2026, an estimated $7.67K.
  • ResMed made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2365 holding.
  • NewEdge Advisors first reported a position in ResMed in Q3 2019 and has held it in 22 quarters since.
  • NewEdge Advisors's ResMed position peaked at $991K in Q3 2024.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.